United States Healthcare Analytical Testing Services Market to hit US$ 14.7 Billion by 2030 | Top Companies - Pharmaceutical Product Development LLC, Eurofins Scientific, SGS SA

"The Global Healthcare Analytical Testing Services Market reached USD 6.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 14.7 billion by 2030. The global Healthcare Analytical Testing Services Market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/healthcare-analytical-testing-services-market?sp

United States: Recent Industry Developments

✅ In November 2025, Labcorp expanded its analytical testing services by launching a new high-throughput biologics testing platform for COVID-19 therapeutics and vaccines. The platform accelerates sample processing while ensuring high accuracy and compliance with FDA standards. It strengthens Labcorp's role as a key partner in U.S. healthcare analytical testing.

✅ In October 2025, Charles River Laboratories inaugurated a new facility in Massachusetts dedicated to advanced preclinical and clinical testing services for biologics and gene therapies. The expansion enhances capacity for pharmacokinetics, immunogenicity, and safety testing. It reflects Charles River's strategic investment in next-generation analytical solutions.

✅ In September 2025, Eurofins Scientific announced the integration of AI-driven analytical platforms for drug stability, potency, and impurity testing in the U.S. labs. This automation reduces turnaround times and improves reproducibility across complex testing workflows. It signals growing reliance on digital technologies in analytical testing services.

✅ In August 2025, SGS Life Sciences launched specialized bioanalytical services for gene and cell therapy products, including viral vector quantification and biomarker analysis. The services target accelerated clinical trial timelines and regulatory compliance. It demonstrates SGS's expansion into high-value precision testing markets.

Japan: Recent Industry Developments

✅ In November 2025, Shimadzu Corporation launched an advanced mass spectrometry and chromatography platform for pharmaceutical and clinical testing services. The platform improves detection sensitivity and throughput for biologics and small-molecule drugs. It reinforces Japan's analytical testing infrastructure and capabilities.

✅ In October 2025, Sysmex Corporation expanded its contract testing services to include advanced hematology, immunology, and biomarker assays for clinical research organizations. The expansion supports Japan's growing demand for precise, high-quality testing in drug development. It highlights the country's commitment to advanced analytical technologies.

✅ In September 2025, Fujifilm Wako Pure Chemical Corporation introduced automated bioanalytical workflows for gene and protein-based therapeutics, improving reproducibility and reducing turnaround times in pharmaceutical testing. The initiative reflects the increasing role of automation and digital solutions in Japanese healthcare analytical testing services.

✅ In August 2025, Mitsubishi Chemical Medience Corporation announced a strategic partnership with domestic hospitals to provide large-scale laboratory testing services, focusing on infectious disease and clinical biomarker analysis. The collaboration enhances capacity and supports rapid data generation for healthcare decision-making. It emphasizes Japan's commitment to high-quality analytical testing infrastructure.

Healthcare Analytical Testing Services Market: Drivers

The healthcare analytical testing services market is witnessing strong growth as the pharmaceutical, biotechnology, and medical device industries increasingly rely on accurate and reliable testing for product quality, safety, and regulatory compliance. These services, including chemical, microbiological, and bioanalytical testing, are critical across drug development, clinical trials, and post-market surveillance. Rising regulatory requirements from agencies such as the FDA, EMA, and ICH are driving demand for outsourced analytical testing to ensure adherence to stringent quality standards. Additionally, the growing complexity of biologics, cell and gene therapies, and personalized medicines is fueling the need for advanced analytical solutions.

Technological advancements in high-throughput screening, chromatography, mass spectrometry, and molecular diagnostics are enhancing the precision and efficiency of healthcare analytical testing. Contract research organizations (CROs) and specialized testing laboratories are increasingly offering integrated services, from raw material characterization to stability and impurity profiling. The expansion of pharmaceutical manufacturing in emerging markets and the growing trend of outsourcing non-core activities are further supporting market growth. Moreover, the adoption of automation, AI, and data analytics is improving turnaround times and reducing errors, strengthening the value proposition of analytical testing services. With continuous innovation, regulatory pressure, and increasing complexity of healthcare products, the healthcare analytical testing services market is poised for sustained, technology-driven expansion.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/healthcare-analytical-testing-services-market?sp

Healthcare Analytical Testing Services Market: Major Players

Pharmaceutical Product Development, LLC (PPD), Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc., Steris, and Charles River Laboratories among others.

Segment Covered in the Healthcare Analytical Testing Services Market:

By Test Type
The market is segmented into Bioanalytical Testing Services, Method Development & Validation, Stability Testing, Drug Substances, and Others. Bioanalytical testing services dominate the segment due to their critical role in determining the pharmacokinetics and bioavailability of drugs. Method development & validation ensures accuracy and reliability in analytical procedures, making it a vital service in regulatory compliance. Stability testing evaluates drug shelf life and formulation consistency under different conditions, while drug substance testing supports quality control throughout the manufacturing process. The others segment includes specialized analytical solutions tailored to niche therapeutic applications.

By End-User
Based on end-user, the market includes Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Contract Research Organizations (CROs). Pharmaceutical and biopharmaceutical companies lead the market due to extensive R&D and regulatory testing requirements. Medical device companies utilize these services to validate material safety and biocompatibility, while CROs are expanding their presence as outsourcing partners offering cost-effective and specialized analytical capabilities.

Research Process:

Both primary and secondary data sources have been used in the Healthcare Analytical Testing Services Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Healthcare Analytical Testing Services Market Research Industry:

➠ Who leads the Healthcare Analytical Testing Services industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Healthcare Analytical Testing Services market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Healthcare Analytical Testing Services market growth?
➠ What are the dominant sales and distribution strategies in the Healthcare Analytical Testing Services industry?

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=healthcare-analytical-testing-services-market
(Purchase 2 or more Repots and get 50% Discount)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.